GlassScriptPhysician profile
Tracy Renae Schmidt
NPI 1134736721
$8,919.52
in general payments reported to CMS, 2019-2025
54 companies · $1,716 in 2025
The $1,716 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $915 · 2022: $1,360 · 2023: $2,338 · 2024: $2,591 · 2025: $1,716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,382 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,381.57 |
| Education | $263.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,364.87 | 2021-2025 | |
| Ucb, INC. | $735.39 | 2021-2025 | Briviact, Nayzilam, Rystiggo |
| Novartis Pharmaceuticals Corporation | $601.39 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $585.58 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Pfizer INC. | $356.07 | 2023-2025 | |
| Sk Life Science, INC. | $296.76 | 2021-2025 | |
| Lilly USA, LLC | $294.84 | 2021-2025 | Amyvid, Emgality, Reyvow |
| Acadia Pharmaceuticals INC | $248.56 | 2023-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $225.02 | 2021-2025 | Ultomiris |
| Biogen, INC. | $206.22 | 2021-2025 | Vumerity, Tysabri, Avonex |
| Eisai INC. | $201.44 | 2022-2024 | |
| Emd Serono, INC. | $184.85 | 2022-2025 | Mavenclad |
| Lundbeck LLC | $180.60 | 2021-2025 | Rexulti, Vyepti |
| Genentech USA, INC. | $177.30 | 2022-2024 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Tg Therapeutics, INC. | $173.05 | 2023-2025 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.